Over-the-Counter Hearing Aid Act of 2017

Great Seal of the United States (obverse)

Over-the-Counter Hearing Aid Act of 2017

The Over-the-Counter Hearing Aid Act of 2017 (OTC Hearing Aid Act) is a significant piece of legislation passed by the United States Congress that amends the Federal Food, Drug, and Cosmetic Act. It was signed into law by the President on August 18, 2017. This act allows for the sale of over-the-counter (OTC) hearing aids for adults with perceived mild to moderate hearing loss. The legislation aims to increase accessibility to hearing aids for millions of Americans and reduce the cost associated with these medical devices.

Background

Prior to the enactment of the OTC Hearing Aid Act, hearing aids were primarily available through audiologists or licensed hearing professionals. This process often included comprehensive hearing tests, fittings, and potentially high costs for the devices themselves. The need for more accessible and affordable hearing solutions was recognized by lawmakers, healthcare professionals, and consumer advocacy groups, leading to the proposal and eventual passage of the act.

Provisions

The OTC Hearing Aid Act mandates the creation of a new category of over-the-counter hearing aids. Key provisions of the act include:

• Allowing adults with mild to moderate hearing loss to purchase hearing aids without a prescription.
• Directing the Food and Drug Administration (FDA) to establish regulations concerning the safety, labeling, and manufacturing of OTC hearing aids.
• Requiring the FDA to ensure that OTC hearing aids meet the same high standards for safety and efficacy as prescription hearing aids.

Impact

The Over-the-Counter Hearing Aid Act of 2017 has several anticipated impacts:

• Increased Accessibility: By allowing OTC sales, the act makes hearing aids more accessible to those who might have previously foregone assistance due to cost or availability.
• Cost Reduction: The competition generated by OTC sales is expected to lead to lower prices for consumers.
• Innovation and Competition: The new market for OTC hearing aids encourages innovation and competition among manufacturers, potentially leading to advancements in hearing aid technology.

Controversy and Criticism

While the act has been praised for its potential to improve access and reduce costs, there have been concerns regarding the self-diagnosis of hearing loss and the ability of consumers to select and fit hearing aids without professional assistance. Critics argue that without proper evaluation and fitting, users may not experience the full benefits of hearing aids, or in some cases, could cause further damage to their hearing.

Implementation

The FDA was given three years from the date of enactment to issue the required regulations for the implementation of the OTC Hearing Aid Act. This includes guidelines for manufacturing, safety, and labeling standards. The act represents a significant shift in how hearing aids are distributed and sold in the United States, with the potential to impact millions of Americans with hearing loss.

See Also

• Hearing loss
• Food and Drug Administration
• Federal Food, Drug, and Cosmetic Act